Sphingosine-1-phosphate as an indicator for deciding the use of adjuvant corticosteroids therapy in community-acquired pneumonia (sphingosine-1-phosphate and pneumonia trial): Study protocol for a randomized, placebo-controlled trial

INTRODUCTION: Pneumonia is one of the leading causes of death worldwide, represents a potentially life-threatening condition. In recent studies, adjuvant corticosteroids therapy has been shown to improve outcome in severe community-acquired pneumonia (CAP); however, the treatment response to cortico...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Shih-Chang, Huang, Wen-Cheng, Liu, Chung-Te, Hsu, Yuan-Pin, Chang, Jer-Hwa, Huang, Shau-Ku, Hsu, Chin-Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756703/
https://www.ncbi.nlm.nih.gov/pubmed/31568009
http://dx.doi.org/10.1097/MD.0000000000017278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756703/
https://www.ncbi.nlm.nih.gov/pubmed/31568009
http://dx.doi.org/10.1097/MD.0000000000017278

Ejemplares similares